| AN | Anorexia Nervosa |
| BHI | Brain-Hearth Infusion |
| BPA | Bisphenol A |
| CIAs | Critically Important Antimicrobials |
| CIC | Centro de Instrumentación Científica |
| EC | Enzyme Commission number |
| EFSA | European Food Safety Authority |
| GRAS | Generally Recognized as Safe |
| HC | Healthy control |
| HIAs | Highly Important Antimicrobials |
| IPBLN | Institute of Parasitology and Biomedicine “López-Neyra” |
| JECFA | Joint FAO/WHO Expert Committee on Food AdditivesLiquid |
| LC-MS/MS | Liquid Chromatography-Mass Spectrometry |
| MCL | Maximum Composite Likelihood |
| MDC | Microbiota Disrupting Chemicals |
| MetS | Metabolic syndrome |
| MIC | Minimum Inhibitory Concentration |
| MRS | Man-Rogosa-Sharpe |
| NAFLD | Nonalcoholic fatty liver disease |
| NCBI | National Center for Biotechnology Information |
| NGP | Next Generation Probiotics |
| NGS | Next Generation Sequencing |
| NMR | Nuclear Magnetic Resonance |
| NRPS | Nonribosomal Peptide-synthetase |
| OB | Obesity |
| OW | Over-weigth |
| PKs | Poliketides |
| QPS | Qualified Presumption of Safety |
| SN | Supernatant |
| T1D | Type 1 Diabetes |
| T2D | Type 2 Diabetes |
| WGS | Whole Genome Sequences |
| WHO | World Health Organization |